12-YEAR FOLLOW-UP OF A BENIGN YELLOW DOT MACULOPATHY CASE.

Retin Cases Brief RepSep 1, 2026
Case ReportOphthalmology

Annamaria Nunziata, Sebastiano Del Fabbro, Alessio Antropoli et al.

✦ AI-curated · Sources linked

Case in brief

A patient with benign yellow dot maculopathy (BYDM) was followed for 12 years, demonstrating characteristic yellow macular dots without structural abnormalities. Initial imaging revealed hyperautofluorescent dots and subnormal electro-oculography responses, indicating retinal pigment epithelium dysfunction. Throughout the follow-up, no progression of structural or functional changes was noted, affirming the nonprogressive nature of BYDM.

Diagnostic / clinical pearl

Clinicians should recognize that benign yellow dot maculopathy is a stable condition over time, characterized by yellow macular dots and preserved visual function, despite subtle functional changes.

Why it matters

Understanding the long-term stability of BYDM can aid in differentiating it from other macular disorders, reducing unnecessary interventions and anxiety for patients.

Source

Published in Retin Cases Brief Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.